Q4 2022 Holdings
Filed 2023-02-14 | 116 holdings | $5.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech LTD(SVA) | COM | P8696W104 | $340.0M | 2,718,735 | 6.5% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $201.7M | 380,500 | 3.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $186.0M | 2,584,900 | 3.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $180.4M | 3,898,200 | 3.5% |
| Humana Inc(HUM) | COM | 444859102 | $178.6M | 348,700 | 3.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $167.2M | 1,615,210 | 3.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $164.6M | 620,500 | 3.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $136.6M | 5,250,000 | 2.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $130.2M | 14,567,176 | 2.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $126.0M | 972,300 | 2.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $119.5M | 4,572,289 | 2.3% |
| Stryker Corporation(SYK) | COM | 863667101 | $117.6M | 481,000 | 2.2% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $117.4M | 913,812 | 2.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $112.5M | 22,362,850 | 2.2% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $111.3M | 202,200 | 2.1% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $85.8M | 17,233,668 | 1.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $82.1M | 687,700 | 1.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $80.6M | 1,679,417 | 1.5% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $79.3M | 2,824,832 | 1.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $78.4M | 271,500 | 1.5% |
| Natera Inc(NTRA) | COM | 632307104 | $78.2M | 1,946,353 | 1.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $77.6M | 7,619,135 | 1.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $75.3M | 1,993,600 | 1.4% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $74.6M | 8,740,887 | 1.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $71.5M | 258,200 | 1.4% |
| Pfizer Inc(PFE) | COM | 717081103 | $71.4M | 1,393,600 | 1.4% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $66.6M | 7,447,140 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $64.2M | 860,500 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $61.5M | 1,283,126 | 1.2% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $60.7M | 7,006,861 | 1.2% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $60.6M | 10,039,691 | 1.2% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $59.5M | 1,220,300 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $58.5M | 3,196,876 | 1.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $58.2M | 1,283,692 | 1.1% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $57.1M | 6,563,077 | 1.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $53.2M | 2,029,300 | 1.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $52.8M | 9,011,437 | 1.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $51.5M | 12,147,877 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $51.1M | 2,006,500 | 1.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $48.9M | 3,322,488 | 0.9% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $48.3M | 73,114,592 | 0.9% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $46.6M | 3,658,869 | 0.9% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $45.8M | 3,368,000 | 0.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $45.3M | 1,149,100 | 0.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $43.4M | 2,758,434 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $43.0M | 2,160,941 | 0.8% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $42.4M | 4,180,768 | 0.8% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $39.9M | 5,559,528 | 0.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $39.6M | 1,747,555 | 0.8% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $38.7M | 4,708,900 | 0.7% |